NYXH Nyxoah S.A.
Healthcare$2.70-5.92%ClosedMarket Cap: $100.8M
As of 2026-05-26
Valuation
P/E (TTM)
—
PEG
—
P/B
2.96
P/S
5.64
EV/EBITDA
-1.37
DCF Value
$-78.30
FCF Yield
-79.6%
Div Yield
0.0%
Margins & Returns
Gross Margin
48.3%
Operating Margin
-527.2%
Net Margin
-527.8%
ROE
-164.4%
ROA
-87.9%
ROIC
-116.2%
Income Statement
Periods shown are fiscal year quarters (may differ from calendar year)
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q1 null | $7.4M | 30.2% | $-23.7M | $-18.4M | $— | — |
| Q4 null | $5.6M | 64.2% | $-18.3M | $-23.5M | $— | — |
| FY null | $10.0M | 63.1% | $-82.9M | $-90.1M | $— | — |
| Q3 null | $2.0M | 60.5% | $-24.2M | $-23.6M | $— | — |
| Q2 null | $1.3M | 63.4% | $-19.9M | $-20.6M | $— | — |
| Q1 null | $1.1M | 61.8% | $-20.6M | $-22.4M | $— | — |
| Q4 null | $1.3M | 73.5% | $-18.3M | $-17.1M | $— | — |
| FY null | $4.5M | 65.7% | $-58.8M | $-59.2M | $— | — |
| Q3 null | $1.3M | 61.9% | $-15.0M | $-17.1M | $— | — |
| Q2 null | $771.0K | 63.6% | $-13.3M | $-13.1M | $— | — |
| Q1 null | $1.2M | 62.7% | $-12.2M | $-11.9M | $— | — |
| Q4 2023 | $1.8M | 60.2% | $-10.8M | $-10.9M | $-0.38 | — |